Fondazione Icona

This study follows 5,000 HIV-negative adults in Italy who are taking or starting PrEP, a daily pill that prevents HIV. Researchers will track how well PrEP works in real life, how often people take it, and any side effects. The goal is to gather data to help eliminate new HIV inf…